Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy

被引:76
|
作者
Campi, Irene [1 ,2 ,3 ]
Gennari, Luigi [4 ]
Merlotti, Daniela [4 ]
Mingiano, Christian [4 ]
Frosali, Alessandro [4 ]
Giovanelli, Luca [1 ,2 ,5 ]
Torlasco, Camilla [6 ,7 ]
Pengo, Martino F. [6 ,7 ]
Heilbron, Francesca [6 ,7 ]
Soranna, Davide [8 ]
Zambon, Antonella [8 ,9 ]
Di Stefano, Marta [1 ,2 ,5 ]
Aresta, Carmen [1 ,2 ,5 ]
Bonomi, Marco [1 ,2 ,5 ]
Cangiano, Biagio [1 ,2 ,5 ]
Favero, Vittoria [1 ,2 ,5 ]
Fatti, Letizia [1 ,2 ,5 ]
Perego, Giovanni Battista [6 ]
Chiodini, Iacopo [1 ,2 ,5 ]
Parati, Gianfranco [6 ,7 ]
Persani, Luca [1 ,2 ,5 ]
机构
[1] Ist Auxol Italiano, Dept Endocrine & Metab Dis, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[2] Ist Auxol Italiano, Lab Endocrine & Metab Res, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[4] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, IRCCS, Milan, Italy
[7] Univ Milano Bicocca, Dept Med & Surg, I-20100 Milan, Italy
[8] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[9] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
关键词
Vitamin D; COVID-19; Mortality; Interleukin-6; TOCILIZUMAB; DEFICIENCY; RISK;
D O I
10.1186/s12879-021-06281-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Vitamin D deficiency has been suggested to favor a poorer outcome of Coronavirus disease-19 (COVID-19). We aimed to assess if 25-hydroxyvitamin-D (25OHD) levels are associated with interleukin 6 (IL-6) levels and with disease severity and mortality in COVID-19. Methods We prospectively studied 103 in-patients admitted to a Northern-Italian hospital (age 66.1 +/- 14.1 years, 70 males) for severely-symptomatic COVID-19. Fifty-two subjects with SARS-CoV-2 infection but mild COVID-19 symptoms (mildly-symptomatic COVID-19 patients) and 206 subjects without SARS-CoV-2 infection were controls. We measured 25OHD and IL-6 levels at admission and focused on respiratory outcome during hospitalization. Results Severely-symptomatic COVID-19 patients had lower 25OHD levels (18.2 +/- 11.4 ng/mL) than mildly-symptomatic COVID-19 patients and non-SARS-CoV-2-infected controls (30.3 +/- 8.5 ng/mL and 25.4 +/- 9.4 ng/mL, respectively, p < 0.0001 for both comparisons). 25OHD and IL-6 levels were respectively lower and higher in severely-symptomatic COVID-19 patients admitted to intensive care Unit [(ICU), 14.4 +/- 8.6 ng/mL and 43.0 (19.0-56.0) pg/mL, respectively], than in those not requiring ICU admission [22.4 +/- 1.4 ng/mL, p = 0.0001 and 16.0 (8.0-32.0) pg/mL, p = 0.0002, respectively]. Similar differences were found when comparing COVID-19 patients who died in hospital [13.2 +/- 6.4 ng/mL and 45.0 (28.0-99.0) pg/mL] with survivors [19.3 +/- 12.0 ng/mL, p = 0.035 and 21.0 (10.5-45.9) pg/mL, p = 0.018, respectively). 25OHD levels inversely correlated with: i) IL-6 levels (rho - 0.284, p = 0.004); ii) the subsequent need of the ICU admission [relative risk, RR 0.99, 95% confidence interval (95%CI) 0.98-1.00, p = 0.011] regardless of age, gender, presence of at least 1 comorbidity among obesity, diabetes, arterial hypertension, creatinine, IL-6 and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count; iii) mortality (RR 0.97, 95%CI, 0.95-0.99, p = 0.011) regardless of age, gender, presence of diabetes, IL-6 and C-reactive protein and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count. Conclusion In our COVID-19 patients, low 25OHD levels were inversely correlated with high IL-6 levels and were independent predictors of COVID-19 severity and mortality.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Vitamin D assessment in patients with COVID-19 virus and correlation with severity
    Yosef, Tarek M.
    Saleh, Shereen A.
    Ali, Sara Fekry
    Ahmed, Ahmed Elmetwally
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01)
  • [42] Genetic Variations of the Vitamin D Metabolic Pathway and COVID-19 Susceptibility and Severity: Current Understanding and Existing Evidence
    Charoenngam, Nipith
    Jaroenlapnopparat, Aunchalee
    Mettler, Sofia K.
    Grover, Ashna
    BIOMEDICINES, 2023, 11 (02)
  • [43] Vitamin D and COVID-19
    Trovas, George
    Tournis, Symeon
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 20 (01): : 207 - 208
  • [44] Vitamin D and COVID-19
    George Trovas
    Symeon Tournis
    Hormones, 2021, 20 : 207 - 208
  • [45] Vitamin D and Covid-19
    Piraux, Arthur
    ACTUALITES PHARMACEUTIQUES, 2021, 60 (605): : 52 - 55
  • [46] Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
    Mercola, Joseph
    Grant, William B.
    Wagner, Carol L.
    NUTRIENTS, 2020, 12 (11) : 1 - 24
  • [47] Role of vitamin D in preventing of COVID-19 infection, progression and severity
    Ali, Nurshad
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (10) : 1373 - 1380
  • [48] Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
    Sulli, Alberto
    Gotelli, Emanuele
    Casabella, Andrea
    Paolino, Sabrina
    Pizzorni, Carmen
    Alessandri, Elisa
    Grosso, Marco
    Ferone, Diego
    Smith, Vanessa
    Cutolo, Maurizio
    NUTRIENTS, 2021, 13 (03) : 1 - 13
  • [49] Vitamin D and morbidity in children with Multisystem inflammatory syndrome related to Covid-19
    Rivera, Diana Torpoco
    Misra, Amrit
    Sanil, Yamuna
    Sabzghabaei, Natalie
    Safa, Raya
    Garcia, Richard U.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2022, 66
  • [50] Vitamin D in patients with COVID-19: is there a room for it?
    Bahat, Gulistan
    Sacar, Duygu Erbas
    Petrovic, Mirko
    ACTA CLINICA BELGICA, 2023, 78 (01) : 71 - 77